14.3 Acute or Critical Valvular Heart Emergencies

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

14.3 Acute or Critical Valvular Heart Emergencies

Key Takeaways Explain This Topic AI

Acute severe aortic regurgitation (AR) causes sudden, massive volume overload into a non-compliant left ventricle, precipitating an extreme rise in left ventricular end-diastolic pressure (LVEDP), premature mitral valve closure, flash pulmonary edema, and rapid cardiogenic shock.

Physical findings of acute severe AR dramatically differ from chronic AR: the diastolic murmur is soft, short, low-pitched, and early (due to rapid pressure equalization between the aorta and LV), while classic peripheral signs of chronic wide pulse pressure (Corrigan water-hammer pulse, Duroziez sign) are completely ABSENT.

The intra-aortic balloon pump (IABP) is ABSOLUTELY CONTRAINDICATED in acute aortic regurgitation because balloon inflation during diastole increases aortic diastolic pressure and drives retrograde flow into the left ventricle, causing catastrophic LV distension, pulmonary edema, and death.

Acute severe mitral regurgitation (MR) commonly results from posteromedial papillary muscle rupture (classically 3 to 5 days post-inferior STEMI due to solitary perfusion from the posterior descending artery), chordal rupture, or infective endocarditis; unlike acute AR, acute MR benefits profoundly from IABP counterpulsation and IV sodium nitroprusside as a bridge to emergent valve repair or replacement.

In critical aortic stenosis (valve area <=0.6-0.8 cm²), cardiac output is mechanically fixed; aggressive afterload reducers (ACE inhibitors, nitroprusside) and nitrates are strictly contraindicated because systemic vasodilation causes precipitous collapse of mean arterial pressure and coronary perfusion, triggering ventricular fibrillation and cardiac arrest.

Last updated: September 2026

Acute Severe Aortic Regurgitation (AR)

Acute severe aortic regurgitation is an immediately life-threatening cardiovascular emergency characterized by sudden, massive retrograde blood flow from the aorta into the left ventricle during diastole. Without emergency surgical intervention, acute severe AR carries an in-hospital mortality exceeding 50%.

Etiological Spectrum

Infective Endocarditis (IE) : Rapid bacterial destruction, cusp perforation, vegetative prolapse, or perivalvular ring abscess disrupting the aortic valve leaflets (most commonly Staphylococcus aureus , viridans group streptococci, or enterococci).

Stanford Type A Aortic Dissection : Retrograde propagation of an ascending aortic intimal tear into the aortic root, detaching the commissural attachments of the aortic cusps, causing cusp flail or prolapse into the left ventricular outflow tract.

Closed Blunt Chest Trauma : High-velocity deceleration injuries (motor vehicle accidents, crush injuries) producing acute transverse tear or avulsion of the aortic cusps.

Iatrogenic / Post-Procedural : Acute failure or severe paravalvular regurgitation following transcatheter aortic valve replacement (TAVR) or balloon aortic valvuloplasty.

Pathophysiology: The Mechanics of Hemodynamic Collapse

Absence of Compensatory Dilation : In chronic aortic regurgitation, the left ventricle adapts gradually over decades through eccentric hypertrophy and progressive chamber dilation, increasing ventricular compliance to accommodate regurgitant volumes exceeding 100 mL with normal filling pressures.

Extreme Rise in LVEDP : In acute AR, a normal-sized, non-hypertrophied, non-compliant left ventricle is suddenly overwhelmed by a massive diastolic regurgitant volume. Because the non-compliant LV cannot acutely dilate, left ventricular end-diastolic pressure (LVEDP) skyrockets to >35–45 mm Hg.

Premature Mitral Valve Closure : As LVEDP escalates precipitously during mid-to-late diastole, it surpasses left atrial pressure, abruptly slamming the mitral valve shut before ventricular systole begins (on echocardiography, the mitral valve C-point precedes the onset of the QRS complex). While this premature closure partially protects the left atrium and pulmonary venous bed from the full magnitude of peak LV end-diastolic pressures, left atrial and pulmonary capillary wedge pressures remain severely elevated.

Cardiovascular Collapse : The sudden rise in pulmonary venous pressure precipitates flash pulmonary edema. Simultaneously, effective forward stroke volume plummets, causing profound cardiogenic shock, lactic acidosis, and compensatory peripheral vasoconstriction. ACUTE VS. CHRONIC AORTIC REGURGITATION

• CHRONIC AORTIC REGURGITATION ACUTE SEVERE AORTIC REGURGITATION
• ┌───────────────────────────────────────┐ ┌───────────────────────────────────────┐
• │ • Gradual eccentric LV dilation │ │ • Normal-sized, non-compliant LV │
• │ • Normal or slightly elevated LVEDP │ │ • Precipitous surge in LVEDP (>40mmHg)│
• │ • Widened pulse pressure (>60-80 mmHg)│ │ • Normal or NARROW pulse pressure │
• │ • Bounding peripheral pulses │ │ • Weak, thready pulses, cool limbs │
• │ • Water-hammer (Corrigan) pulse │ │ • Peripheral signs completely ABSENT │
• │ • Duroziez, Traube, Quincke signs │ │ • S1 soft or completely ABSENT │
• │ • Loud, long holodiastolic murmur │ │ • Soft, short, early diastolic murmur │
• │ • Well-tolerated for many years │ │ • Flash pulmonary edema + shock │
• └───────────────────────────────────────┘ └───────────────────────────────────────┘
• Physical Examination: The Great Clinical Paradox

The physical findings of acute severe AR are strikingly subtle and diametrically opposed to the classic signs of chronic AR, frequently misleading clinicians:

Pulse Pressure : Pulse pressure is normal or narrowed (e.g., 90/70 mm Hg) due to low forward stroke volume, severe sinus tachycardia, and marked peripheral arterial vasoconstriction.

Peripheral Arterial Signs : All classic eponymic peripheral signs of chronic wide pulse pressure—Corrigan water-hammer pulse, Duroziez double murmur, Traube pistol-shot sounds, Quincke capillary pulsations, and de Musset head-nodding—are completely ABSENT .

Auscultation of Heart Sounds : The first heart sound (S1) is markedly diminished or completely absent because the mitral valve has already closed prematurely in late diastole.

The Murmur of Acute AR : Remarkably, the murmur is a short, soft, low-pitched early diastolic murmur heard at the left lower sternal border. It is frequently missed or dismissed as insignificant because the rapidly rising LVEDP quickly equilibrates with aortic diastolic pressure in early diastole, abolishing the transvalvular regurgitant gradient before mid-diastole. A loud S3 gallop and diffuse coarse pulmonary crackles are universally present.

Diagnostic Evaluation

Transthoracic (TTE) & Transesophageal Echocardiography (TEE) : Emergent imaging modality of choice. Directly demonstrates flail leaflets, vegetative masses, cusp perforation, or an aortic root intimal flap. Pathognomonic hemodynamic signs include premature mitral valve closure, premature aortic valve opening, a short pressure half-time (< 200 ms indicating rapid pressure equilibration), and a broad regurgitant jet width (> 65% of LVOT).

Chest Radiography : Severe bilateral alveolar pulmonary edema with a normal cardiac silhouette (absence of cardiomegaly).

Emergency Stabilization & Crucial Contraindications

Medical therapy is strictly a temporizing bridge to emergency open cardiothoracic surgery:

Inotropic Support : Intravenous dobutamine or dopamine improves forward contractility and cardiac output. The induced mild sinus tachycardia is physiologically protective because it shortens diastole, thereby reducing the duration of regurgitant flow per cardiac cycle.

Afterload Reduction : Intravenous sodium nitroprusside reduces systemic vascular resistance and promotes forward aortic flow, but may ONLY be administered if systolic blood pressure is maintained (> 90–100 mm Hg).

THE ABSOLUTE CONTRAINDICATION - Intra-Aortic Balloon Pump (IABP) : The IABP is STRICTLY AND ABSOLUTELY CONTRAINDICATED in acute aortic regurgitation. The IABP balloon inflates during diastole; in the presence of an incompetent aortic valve, diastolic balloon inflation forces a massive volume of blood retrogradely across the aortic valve directly into the non-compliant left ventricle. This triggers immediate catastrophic ventricular distension, worsening pulmonary edema, and fatal electromechanical collapse.

AVOID BETA-BLOCKERS : Beta-adrenergic antagonists are contraindicated in acute AR. Beta-blockade produces bradycardia, which lengthens diastole and drastically increases the volume of regurgitant flow per beat, accelerating hemodynamic decompensation.

Definitive Intervention : Emergent cardiothoracic surgical valve replacement (AVR) or repair, combined with composite aortic root replacement if Type A dissection is present.

Acute Severe Mitral Regurgitation (MR)

Acute severe mitral regurgitation results from the sudden disruption of any component of the mitral valve apparatus—leaflets, chordae tendineae, or papillary muscles—allowing massive systolic backflow of blood into a non-compliant left atrium.

Etiological Spectrum

Acute Papillary Muscle Rupture :

Occurs classically 3 to 5 days (range 2 to 7 days) following an acute myocardial infarction.

The Posteromedial Papillary Muscle : Accounts for >75% of ruptures. It receives a solitary arterial blood supply from the posterior descending artery (branch of the RCA in a right-dominant system, or LCx in a left-dominant system), rendering it acutely vulnerable to ischemic necrosis during inferior STEMIs.

In contrast, the anterolateral papillary muscle receives a dual blood supply from both the left anterior descending (LAD) and left circumflex (LCx) arteries, making rupture rare.

Rupture of Chordae Tendineae : Spontaneous rupture in severe myxomatous degeneration (mitral valve prolapse), infective endocarditis, blunt chest trauma, or connective tissue disorders (Marfan syndrome, Ehlers-Danlos syndrome).

Leaflet Perforation or Annular Destruction : Rapid bacterial erosion secondary to acute infective endocarditis.

Pathophysiology & Hemodynamics

The left atrium in acute MR is normal-sized and non-compliant. During systole, a massive regurgitant volume is ejected retrogradely into the stiff atrium, generating giant systolic regurgitant waves (V waves > 50 mm Hg) .

These extreme pressures are instantaneously transmitted backward into the pulmonary venous circulation, overwhelming capillary oncotic pressure and causing acute flash pulmonary edema and acute pulmonary arterial hypertension.

Forward stroke volume into the systemic circulation collapses, triggering severe cardiogenic shock and compensatory tachycardia.

Physical Examination Nuances

Presentation : Severe acute dyspnea, orthopnea, cyanosis, pink frothy sputum, diaphoresis, and cold clammy extremities with severe hypotension.

The Murmur of Acute MR : In stark contrast to the loud, high-pitched holosystolic murmur of chronic MR, the murmur of acute severe MR is frequently soft, decrescendo, early-to-mid systolic , or occasionally completely silent. As left atrial pressure surges rapidly to approach left ventricular systolic pressure in late systole, the transvalvular gradient diminishes, extinguishing the murmur early.

Radiation Paradox : Rupture of the posteromedial papillary muscle causes flail of the posterior leaflet. This directs the regurgitant jet anteriorly and medially against the interatrial septum toward the base of the heart and aorta, producing a murmur heard loudest at the right upper sternal border that is frequently mistaken for aortic stenosis ! Flail of the anterior leaflet directs the jet posterolaterally toward the left axilla.

Auscultatory Signs : Prominent S3 gallop and an accentuated pulmonic component of the second heart sound (P2) reflecting acute pulmonary hypertension.

Diagnostic Evaluation

Urgent Echocardiography (TTE & TEE) : Visualizes the flail mitral leaflet, ruptured papillary muscle head prolapsing into the left atrium during systole, eccentric regurgitant jet, and hyperdynamic left ventricular systolic function.

Right Heart Catheterization : Confirms giant systolic V waves on the pulmonary capillary wedge pressure (PCWP) tracing.

Emergency Hemodynamic Stabilization: The Lifesaving Role of IABP

Unlike acute aortic regurgitation, mechanical circulatory support with an intra-aortic balloon pump is highly beneficial and lifesaving in acute mitral regurgitation:

Intra-Aortic Balloon Pump (IABP) : Deflation of the balloon immediately prior to ventricular systole creates a sudden pressure drop in the ascending aorta, dramatically decreasing left ventricular afterload. This "unloads" the left ventricle, augmenting forward cardiac output into the aorta and significantly reducing regurgitant volume into the left atrium.

Pharmacological Afterload Reduction : Intravenous sodium nitroprusside decreases systemic vascular resistance, favoring forward flow over backward flow. (Administered only if systolic blood pressure is adequate, often combined with inotropic support).

Inotropic Support : Intravenous dobutamine to augment forward contractility in cardiogenic shock.

Definitive Therapy : Emergent surgical mitral valve repair or replacement.

Critical Aortic Stenosis in Extremis

Aortic stenosis represents a progressive mechanical obstruction to left ventricular outflow. While chronic severe AS is often managed electively, patients presenting in extremis—with cardiogenic shock, syncope at rest, or acute decompensated heart failure—represent a critical medical emergency.

Diagnostic Criteria for Severe & Critical Aortic Stenosis

Severe Aortic Stenosis :

• Aortic Valve Area (AVA): < 1.0 cm²
• Mean Transvalvular Pressure Gradient: > 40 mm Hg
• Peak Aortic Jet Velocity: > 4.0 m/s

Critical Aortic Stenosis :

Aortic Valve Area (AVA): <= 0.6 to 0.8 cm² (or indexed AVA <= 0.4 cm²/m²).

Pathophysiology of Fixed Outflow Obstruction

The severely calcified, stenotic aortic orifice imposes a rigid, fixed mechanical impedance to left ventricular emptying. The left ventricle undergoes massive concentric hypertrophy to generate high intracavitary pressures (>200 mm Hg) to overcome the gradient.

The hypertrophied ventricle is extremely stiff and non-compliant, with filling heavily dependent on sinus rhythm and elevated atrial kick. Forward cardiac output is fixed and cannot increase in response to exercise, stress, or peripheral vasodilation.

Lethal Pharmacologic Pitfalls (Must Memorize)

ABSOLUTE CONTRAINDICATION TO NITRATES & AGGRESSIVE VASODILATORS : Administration of sublingual/IV nitroglycerin, nitroprusside, hydralazine, or high-dose ACE inhibitors is STRICTLY CONTRAINDICATED . Vasodilation abruptly decreases systemic vascular resistance (SVR) and venous return (preload). Because the left ventricle cannot augment stroke volume across the fixed stenotic orifice, mean arterial pressure collapses precipitously. This causes immediate cessation of coronary perfusion pressure, precipitating severe transmural myocardial ischemia, ventricular fibrillation, and sudden electromechanical arrest!

AVOID AGGRESSIVE DIURESIS : The stiff, hypertrophied left ventricle requires high filling pressures (preload) to achieve adequate end-diastolic stretch. Aggressive diuresis drops preload, causing a catastrophic fall in forward stroke volume and acute circulatory collapse.

AVOID BETA-BLOCKERS IN DECOMPENSATED SHOCK : Negative inotropes depress myocardial contractility, triggering cardiogenic shock in the presence of severe outflow obstruction.

Emergency Management in Extremis

Cautious Volume Optimization : Maintain euvolemia; avoid hypovolemia or fluid overload.

Inotropic & Vasopressor Support : Administer cautious low-dose inotropes (dobutamine) or vasopressors (phenylephrine or norepinephrine) to sustain mean arterial pressure and preserve coronary perfusion without causing tachycardia.

Urgent Mechanical Bridging & Intervention : Emergent balloon aortic valvuloplasty (BAV) serves as a temporary hemodynamic bridge in patients in cardiogenic shock, followed by urgent Transcatheter Aortic Valve Replacement (TAVR) or surgical aortic valve replacement (SAVR).

Master Comparative Matrix of Valvular Emergencies

Clinical Parameter Acute Severe Aortic Regurgitation Acute Severe Mitral Regurgitation Critical Aortic Stenosis in Extremis

Primary Etiologies Infective endocarditis, Type A aortic dissection, chest trauma Papillary muscle rupture (post-inferior MI), chordal rupture, endocarditis Degenerative calcific stenosis, bicuspid aortic valve

Left Ventricular Cavity Normal size, non-compliant, high LVEDP Hyperdynamic, normal size, high LA pressure Concentric hypertrophy, stiff, non-compliant

Pulse Pressure Normal or narrow Normal or narrow Narrow (< 30 mm Hg) with pulsus parvus et tardus

Murmur Characteristics Soft, short, low-pitched early diastolic Soft, decrescendo early-to-mid systolic (may mimic AS) Harsh, late-peaking systolic ejection murmur; soft/absent A2

First Heart Sound (S1) Soft or completely absent Normal or obscured by murmur Normal

Peripheral Signs Peripheral signs of chronic AR ABSENT Normal peripheral findings Pulsus parvus et tardus (slow, delayed carotid upstroke)

Role of IABP ABSOLUTELY CONTRAINDICATED (worsens regurgitation and causes arrest) STRONGLY INDICATED & LIFESAVING (unloads LV, reduces regurgitation) Cautious use as bridge; contraindicated if concurrent AR

Role of Vasodilators Beneficial if SBP permits (nitroprusside) Highly beneficial (nitroprusside unloads LV) STRICTLY CONTRAINDICATED (collapses BP and coronary perfusion)

Definitive Treatment Emergent aortic valve replacement / root repair Emergent mitral valve repair or replacement Emergent TAVR / SAVR (BAV as temporary bridge)

Loading diagram... Emergency Valvular Heart Disease Hemodynamic Management Algorithm